GlassScriptPhysician profile
Fermin Fontan
NPI 1902148885
$86,919.08
in general payments reported to CMS, 2019-2025
8 companies · $42K in 2025
The $42K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.13 · 2021: $18K · 2022: $17K · 2023: $6,793 · 2024: $3,468 · 2025: $42K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $44K · Travel and Lodging: $4,877 · Food and Beverage: $3,113 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $44,000.00 |
| Travel and Lodging | $4,877.27 |
| Food and Beverage | $3,112.78 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $79,917.41 | 2021-2025 | Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $2,740.93 | 2021-2024 | Gore Enform Preperitoneal Biomaterial, Gore Seamguard Bioabsorbable Staple Line Reinforce, Gore Synecor Biomaterial |
| Medtronic, INC. | $2,469.88 | 2021-2025 | Signia, Bravo, Endoflip |
| Davol INC. | $1,389.96 | 2022-2024 | Phasix Mesh |
| Ethicon US, LLC | $134.67 | 2022-2025 | Vistaseal, Surgiflo Hemostatic Matrix, Surgicel Nu-Knit |
| Endogastric Solutions, INC | $122.85 | 2022 | |
| Olympus America INC. | $87.13 | 2019 | |
| Becton, Dickinson and Company | $56.25 | 2025 | Phasix Mesh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fermin Fontan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.